
Shobha Kantamneni
Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617, 1623 |
| Total Applications | 1212 |
| Issued Applications | 306 |
| Pending Applications | 120 |
| Abandoned Applications | 793 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6912933
[patent_doc_number] => 20050176691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Combination therapy for the treatment of estrogen-sensitive disease'
[patent_app_type] => utility
[patent_app_number] => 10/982697
[patent_app_country] => US
[patent_app_date] => 2004-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11972
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176691.pdf
[firstpage_image] =>[orig_patent_app_number] => 10982697
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/982697 | Combination therapy for the treatment of estrogen-sensitive disease | Nov 4, 2004 | Abandoned |
Array
(
[id] => 7098486
[patent_doc_number] => 20050130945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Combination therapy for the treatment of estrogen-sensitive disease'
[patent_app_type] => utility
[patent_app_number] => 10/982533
[patent_app_country] => US
[patent_app_date] => 2004-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11967
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10982533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/982533 | Combination therapy for the treatment of estrogen-sensitive disease | Nov 4, 2004 | Abandoned |
Array
(
[id] => 7127976
[patent_doc_number] => 20050059720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Medicinal compositions for the prevention or treatment of cardiac failure'
[patent_app_type] => utility
[patent_app_number] => 10/977645
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6348
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977645
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977645 | Medicinal compositions for the prevention or treatment of cardiac failure | Oct 28, 2004 | Abandoned |
Array
(
[id] => 7127921
[patent_doc_number] => 20050059665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/969079
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41735
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10969079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/969079 | Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use | Oct 20, 2004 | Abandoned |
Array
(
[id] => 7181338
[patent_doc_number] => 20050124685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning'
[patent_app_type] => utility
[patent_app_number] => 10/945241
[patent_app_country] => US
[patent_app_date] => 2004-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10283
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10945241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/945241 | Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning | Sep 19, 2004 | Abandoned |
Array
(
[id] => 5068969
[patent_doc_number] => 20070190070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system'
[patent_app_type] => utility
[patent_app_number] => 10/590575
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25249
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190070.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590575
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590575 | Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system | Sep 2, 2004 | Abandoned |
Array
(
[id] => 7238337
[patent_doc_number] => 20050080100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Pyridylamino compounds and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/926493
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5528
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926493 | Pyridylamino compounds and methods of use thereof | Aug 25, 2004 | Abandoned |
Array
(
[id] => 7060619
[patent_doc_number] => 20050002979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Method of treating actinic keratosis'
[patent_app_type] => utility
[patent_app_number] => 10/900279
[patent_app_country] => US
[patent_app_date] => 2004-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5464
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10900279
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/900279 | Method of treating actinic keratosis | Jul 27, 2004 | Abandoned |
Array
(
[id] => 7352331
[patent_doc_number] => 20040248977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Rapid growth dairy heifers having reduced mammary fat content'
[patent_app_type] => new
[patent_app_number] => 10/486751
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3567
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486751 | Rapid growth dairy heifers having reduced mammary fat content | Jul 25, 2004 | Abandoned |
Array
(
[id] => 7352200
[patent_doc_number] => 20040248948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Combination therapy'
[patent_app_type] => new
[patent_app_number] => 10/879937
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13141
[patent_no_of_claims] => 106
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10879937
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/879937 | Combination therapy | Jun 28, 2004 | Abandoned |
Array
(
[id] => 5733633
[patent_doc_number] => 20060258750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/562393
[patent_app_country] => US
[patent_app_date] => 2004-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3769
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562393
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562393 | Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions | Jun 21, 2004 | Abandoned |
Array
(
[id] => 7089641
[patent_doc_number] => 20050009754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Use of growth hormone secretagogues for treatment of fibromyalgia'
[patent_app_type] => utility
[patent_app_number] => 10/864667
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15627
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009754.pdf
[firstpage_image] =>[orig_patent_app_number] => 10864667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/864667 | Use of growth hormone secretagogues for treatment of fibromyalgia | Jun 8, 2004 | Abandoned |
Array
(
[id] => 7319266
[patent_doc_number] => 20040224989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'S-lansoprazole compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/863532
[patent_app_country] => US
[patent_app_date] => 2004-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3572
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224989.pdf
[firstpage_image] =>[orig_patent_app_number] => 10863532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/863532 | S-lansoprazole compositions and methods | Jun 7, 2004 | Abandoned |
Array
(
[id] => 7122902
[patent_doc_number] => 20050014731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds'
[patent_app_type] => utility
[patent_app_number] => 10/855944
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3310
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014731.pdf
[firstpage_image] =>[orig_patent_app_number] => 10855944
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/855944 | Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds | May 27, 2004 | Abandoned |
Array
(
[id] => 7122906
[patent_doc_number] => 20050014735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Treatment of Th2 dominated immunological disease states with progesterone receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/855790
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3204
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10855790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/855790 | Treatment of Th2 dominated immunological disease states with progesterone receptor antagonists | May 27, 2004 | Abandoned |
Array
(
[id] => 7155727
[patent_doc_number] => 20050026811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Rage antagonists as agents to reverse amyloidosis and diseases associated therewith'
[patent_app_type] => utility
[patent_app_number] => 10/850238
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21275
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026811.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850238
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850238 | Rage antagonists as agents to reverse amyloidosis and diseases associated therewith | May 19, 2004 | Abandoned |
Array
(
[id] => 10089131
[patent_doc_number] => 09125939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Carbostyril derivatives and mood stabilizers for treating mood disorders'
[patent_app_type] => utility
[patent_app_number] => 10/556600
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12883
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10556600
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556600 | Carbostyril derivatives and mood stabilizers for treating mood disorders | May 18, 2004 | Issued |
Array
(
[id] => 7319347
[patent_doc_number] => 20040225017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Chloramine T based teat cleaner and related process'
[patent_app_type] => new
[patent_app_number] => 10/833431
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2621
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20040225017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833431
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833431 | Chloramine T based teat cleaner and related process | Apr 27, 2004 | Issued |
Array
(
[id] => 7188759
[patent_doc_number] => 20050192356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Synergistic anti-inflammatory pharmaceutical compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/789814
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11200
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192356.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789814 | Synergistic anti-inflammatory pharmaceutical compositions and methods of use | Feb 26, 2004 | Abandoned |
Array
(
[id] => 6991490
[patent_doc_number] => 20050090527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis'
[patent_app_type] => utility
[patent_app_number] => 10/764780
[patent_app_country] => US
[patent_app_date] => 2004-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13424
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090527.pdf
[firstpage_image] =>[orig_patent_app_number] => 10764780
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/764780 | Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis | Jan 25, 2004 | Abandoned |